Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
SureTrader Stock Hero Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 3/28/2015 7:10:36 AM - Followers: 571 - Board type: Free - Posts Today: 3

Cellceutix Corporation (CTIX) 



Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


Management:   http://cellceutix.com/team/
The above link is kept updated.

Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
Product Pipeline:  http://cellceutix.com/pipeline/

Recent News and Press Releases: 

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure

Cellceutix IP - Patent Filings:


Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet



Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Independent Research Initiates Analyst Coverage on Inventergy Global, Inc. (NASDAQ: INVT) with $1.20 Price Target 03/12/2015 08:00:00 AM
CTIX News: Quarterly Report (10-q) 02/09/2015 12:38:38 PM
CTIX News: Amended Statement of Ownership (sc 13g/a) 02/05/2015 05:24:25 PM
CTIX News: Special "Tech Boom" Profile and 4 Companies That May Take Investors for a Growth Ride 01/21/2015 07:00:00 AM
#95145  Sticky Note $CTIX Lead drug info, News, SEC filings, FDA KarinCA 03/21/15 12:39:45 PM
#93207  Sticky Note Tremendous follow through overall. KarinCA 03/02/15 03:58:13 PM
#92697  Sticky Note upcoming catalysts slcimmuno 02/26/15 09:18:08 AM
#90993  Sticky Note An Interview with Cellceutix CEO Leo Ehrlich BigKahuna 02/09/15 03:56:33 PM
#87958  Sticky Note Cellceutix Reports Spleen Lesion 'Disappears' in Patient With starbuxsux 01/20/15 08:25:55 AM
#74575  Sticky Note Cellceutix Announces Positive Top-Line Data From Phase 2b TOB 10/23/14 11:59:10 AM
#96048   I could not get the link to work, Chemdeps 03/28/15 07:10:35 AM
#96047   U know better than most.... Sell = buy TheHound 03/28/15 12:20:37 AM
#96046   Lova Ya Mr. Smith! Money to be made! TheHound 03/28/15 12:16:59 AM
#96045   LOL, agreed, information and speculation overload. We probably havendale 03/27/15 11:04:17 PM
#96044   Should I tell the boss to sell 1/2 etradeedge 03/27/15 10:52:03 PM
#96043   Please tell us about the valuable skills you've scottsmith 03/27/15 10:40:23 PM
#96042   For the record,.. My gut also told me TheHound 03/27/15 09:36:28 PM
#96041   Part time penny trader...full time astrophysicist....that's the Bunny! BIzzy 03/27/15 09:00:56 PM
#96040   National Action Plan for Combating Antibiotic-Resistant Bacteria CallMeCrazy 03/27/15 08:49:37 PM
#96039   So clever. You must be making mega bucks TheDane 03/27/15 07:30:19 PM
#96038   Bleak. But there it is. TheDane 03/27/15 07:25:46 PM
#96037   Warren buffet eats bunnies for a living. When TheHound 03/27/15 07:10:07 PM
#96036   You will be proven wrong very, very shortly, dear. MrW 03/27/15 07:07:49 PM
#96035   I've been watching this stock from a micro TheHound 03/27/15 06:59:38 PM
#96034   Bunny, I am sorry for you that you NanoEngineer 03/27/15 06:27:25 PM
#96033   Hey buddy, Fletch 03/27/15 06:26:23 PM
#96032   What's your price? I was trying for $3.07's. TheHound 03/27/15 06:16:23 PM
#96031   Generally speaking, doctors are men of science. CallMeCrazy 03/27/15 06:13:45 PM
#96030   My good til buy order hasn't filled......Less volume Fletch 03/27/15 05:58:10 PM
#96029   TH, I was feeling the same way about ctix 03/27/15 04:14:28 PM
#96028   All good. The lower we go, the farther TheHound 03/27/15 04:13:33 PM
#96027   Not a good day low volume by the oldguy76 03/27/15 04:12:27 PM
#96026   Tried to pick 20k off the bottom. No TheHound 03/27/15 04:04:15 PM
#96024   Would be a red flag for me too. frrol 03/27/15 03:54:04 PM
#96023   Excellent points. F1ash 03/27/15 03:48:39 PM
#96022   http://www.investorwired.com/penny-stock-movers-cellceutix-ctix-nano-ctle-sky-sk EasyRider 03/27/15 03:42:23 PM
#96021   After reading the interview with POTUS I cant BIzzy 03/27/15 03:29:26 PM
#96020   George, tell us we're going to get good TheHound 03/27/15 03:21:16 PM
#96019   Using a stock promoter like RedChip is a sox040713 03/27/15 03:20:00 PM
#96018   What is funny is you all are trading daydreaming2 03/27/15 03:13:58 PM
#96017   I'm really not concerned about the coffers and havendale 03/27/15 03:13:10 PM
#96016   Being a slick trader is awesome just up BIzzy 03/27/15 03:10:48 PM
#96015   Actually the $2.99 cracking did happen on Monday, sox040713 03/27/15 03:01:55 PM
#96014   So many laughs a week ago. being lazy, TheBunny 03/27/15 02:46:52 PM
#96013   My powder is dry and ready to buy.....next week tombrady12nh 03/27/15 02:33:55 PM
#96012   I can't quit drooling at these prices! TheHound 03/27/15 02:16:07 PM
#96011   Can't wait to buy under $3 next week. jav0033 03/27/15 01:23:34 PM
#96010   WTH is going on with this crap? 3 medic11 03/27/15 01:14:26 PM
#96009   Thx - is the other side of the slcimmuno 03/27/15 01:12:13 PM
#96008   p21 data expected to be released by mid-April, frrol 03/27/15 01:10:21 PM
#96007   Thought this statement was interesting. "The government hopes to F1ash 03/27/15 12:20:38 PM
#96006   Exactly what I like to see here: ctix 03/27/15 12:04:31 PM
#96004   Good to see Pres Obama recognizes the importance frrol 03/27/15 11:54:28 AM
#96003   Monday news: BOD announced, Committee announced, uplist DaubersUP 03/27/15 11:38:38 AM
#96002   Exclusive: Obama on Antibiotic Resistance CallMeCrazy 03/27/15 11:30:22 AM
#96001   Antibiotic-Resistant Germs Target Of New White House Plan CallMeCrazy 03/27/15 11:26:49 AM
#96000   Good chance you are correct. Sellers need I Need Help 03/27/15 11:22:42 AM
#95999   TomB, I think that your example illustrates both loanranger 03/27/15 11:20:29 AM
#95998   Just posted on Cellceutix FaceBook, Sweet Cassius Longinus 03/27/15 11:16:51 AM
#95997   Good analysis, as always. I don't believe the TheMonolith 03/27/15 11:15:18 AM